FDAnews
www.fdanews.com/articles/122822-biocryst-rsquo-s-korean-partner-receives-emergency-use-authorization

BioCryst’s Korean Partner Receives Emergency Use Authorization

December 9, 2009
BioCryst Pharmaceuticals is a development-stage biotech company that will report over $30 million in sales in the December 2009 quarter.
Seeking Alpha